Gregory Borg, MD
Otolaryngology · Montgomery, ALNPI 1487761391
Payments from drug & device makers
Across 93 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$525
- Optinose US, Inc.$467
- Sanofi$387
- Regeneron Healthcare Solutions, Inc.$238
- Intersect ENT, Inc.$84
- Ambu Inc.$79
- plus $162 from 8 others
What the payments were for
- Food & beverage$1,84595%
- Education$985%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 28 | $525 |
| Optinose US, Inc. | 31 | $467 |
| Sanofi | 14 | $387 |
| Regeneron Healthcare Solutions, Inc. | 7 | $238 |
| Intersect ENT, Inc. | 2 | $84 |
| Ambu Inc. | 1 | $79 |
| Stryker | 3 | $47 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $18 |
| Neurent Medical Limited | 1 | $16 |
| Medtronic | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
How this compares
$1,943 in reported general payments places this provider in the 50th percentile of 155 otolaryngology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 119 | $5,006 |
| Fluticasone Propionate | 196 | $3,533 |
| Famotidine | 116 | $2,400 |
| Ipratropium Bromide | 60 | $2,333 |
| Ofloxacin | 30 | $2,220 |
| Levothyroxine Sodium | 196 | $2,063 |
| Omeprazole | 62 | $1,388 |
| Pilocarpine Hcl | 12 | $1,175 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 16 | $942 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 39 | $914 |
| Montelukast Sodium | 39 | $764 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $671 |
| Calcitriol | 30 | $587 |
| Cefprozil | 13 | $540 |
| Cephalexin | 63 | $478 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Montgomery
- James AndersonMontgomery$6K
- Stephen ChandlerMontgomery$4K
- John DavisHoover$344K
- Bradford WoodworthBirmingham$323K
- Kirk WithrowBirmingham$231K
- Michael SillersBirmingham$188K
- Justin TurnerBirmingham$104K
- William McFeelyHuntsville$91K
- Do-Yeon ChoBirmingham$69K
- Jessica GraysonBirmingham$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.